$9.85
11.93%
Nasdaq, Nov 21, 10:00 pm CET
ISIN
US1266381052
Symbol
CVRX

CVRx Inc Stock price

$9.85
-0.22 2.18% 1M
+3.59 57.35% 6M
-2.82 22.26% YTD
-4.92 33.31% 1Y
-2.34 19.20% 3Y
-18.15 64.82% 5Y
-18.15 64.82% 10Y
-18.15 64.82% 20Y
Nasdaq, Closing price Fri, Nov 21 2025
+1.05 11.93%

Key metrics

Basic
Market capitalization
$258.2m
Enterprise Value
$222.5m
Net debt
positive
Cash
$85.1m
Shares outstanding
26.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.6 | 4.5
EV/Sales
4.0 | 3.9
EV/FCF
negative
P/B
5.4
Financial Health
Equity Ratio
53.3%
Return on Equity
-84.4%
ROCE
-50.3%
ROIC
-224.1%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
$56.0m | $57.1m
EBITDA
$-49.6m | $-46.7m
EBIT
$-50.4m | $-51.9m
Net Income
$-52.0m | $-54.2m
Free Cash Flow
$-39.0m
Growth (TTM | estimate)
Revenue
18.4% | 11.3%
EBITDA
14.9% | 20.6%
EBIT
14.5% | 12.8%
Net Income
11.0% | 9.6%
Free Cash Flow
3.7%
Margin (TTM | estimate)
Gross
84.5%
EBITDA
-88.6% | -81.9%
EBIT
-90.0%
Net
-93.0% | -95.0%
Free Cash Flow
-69.7%
More
EPS
$-2.0
FCF per Share
$-1.5
Short interest
8.8%
Employees
206
Rev per Employee
$250.0k
Show more

Is CVRx Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,052 stocks worldwide.

CVRx Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CVRx Inc forecast:

11x Buy
85%
1x Hold
8%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a CVRx Inc forecast:

Buy
85%
Hold
8%
Sell
8%

Financial data from CVRx Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
56 56
18% 18%
100%
- Direct Costs 8.68 8.68
16% 16%
16%
47 47
19% 19%
84%
- Selling and Administrative Expenses 87 87
2% 2%
155%
- Research and Development Expense 11 11
4% 4%
20%
-50 -50
15% 15%
-89%
- Depreciation and Amortization 0.75 0.75
32% 32%
1%
EBIT (Operating Income) EBIT -50 -50
14% 14%
-90%
Net Profit -52 -52
11% 11%
-93%

In millions USD.

Don't miss a Thing! We will send you all news about CVRx Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CVRx Inc Stock News

Neutral
GlobeNewsWire
5 days ago
MINNEAPOLIS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on ...
Neutral
Seeking Alpha
18 days ago
CVRx, Inc. ( CVRX ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Kevin Hykes - President, CEO & Director Jared Oasheim - Chief Financial Officer Conference Call Participants Mike Vallie - Westwicke Partners, LLC John Young - Canaccord Genuity Corp., Research Division Samantha Munoz - Piper Sandler & Co., Research Division Rohin Patel - JPMorgan Chase & Co, Research Di...
Neutral
GlobeNewsWire
about one month ago
MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release third quarter 2025 financial and operating results after market close on Wednesday, Nov. 5, 20...
More CVRx Inc News

Company Profile

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. It has developed the second generation Barostim neo, an implantable system designed to treat heart failure and hypertension. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2000 and is headquartered in Minneapolis, MN.

Head office United States
CEO Kevin Hykes
Employees 206
Founded 2001
Website www.cvrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today